COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant

[1]. NG J.H., BIJOL V., SPARKS M.A., SISE M.E., IZZEDINE H., JHAVERI K.D. Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19. Adv Chronic Kidney Dis. 2020; 27(5):365–76.10.1053/j.ackd.2020.09.003 Search in Google Scholar

[2]. VILLE S., LE BOT S., CHAPELET-DEBOUT A., BLANCHO G., FREMEAUXBACCHI V., DELTOMBE C., et al. Atypical HUS relapse triggered by COVID-19. Kidney Int [Internet]. 2021; 99(1):267–8.10.1016/j.kint.2020.10.030 Search in Google Scholar

[3]. MAT O., GHISDAL L., MASSART A., AYDIN S., GOUBELLA A., BLANKOFF N., et al. Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation. Kidney Int Reports. 2021;6(6):1732–7.10.1016/j.ekir.2021.03.897 Search in Google Scholar

[4]. KAUFELD J.K., REINHARDT M., SCHRÖDER C., BRÄSEN J.H., WIECH T., BRYLKA P., et al. Atypical HUS triggered by infection with SARS-CoV2. Kidney Int Reports. 2021; 6(10):2709-2712.10.1016/j.ekir.2021.07.004 Search in Google Scholar

[5]. ABDEL-WAHAB N., LOPEZ-OLIVO M.A., PINTO-PATARROYO G.P., SUAREZALMAZOR M.E. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus. 2016; 25(14):1520-1531.10.1177/0961203316640912 Search in Google Scholar

[6]. HARZALLAH I., DEBLIQUIS A., DRÉNOU B. Frequency of lupus anticoagulant in COVID-19 patients. Journal of Thrombosis and Haemostasis. 2020; 18(10):2778.10.1111/jth.14937 Search in Google Scholar

[7]. DEVREESE K.M.J., LINSKENS E.A., BENOIT D., PEPERSTRAETE H. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?. J Thromb Haemost. 2020;18(9):2191–201.10.1111/jth.14994 Search in Google Scholar

[8]. PINETON DE CHAMBRUN M., FRERE C., MIYARA M., AMOURA Z., MARTINTOUTAIN I., MATHIAN A., et al. High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?. Journal of Internal Medicine. 2021; 289(3):422-424.10.1111/joim.13126 Search in Google Scholar

[9]. TIWARI N.R., PHATAK S., SHARMA V.R., AGARWAL S.K. COVID-19 and thrombotic microangiopathies. Thromb Res. 2021; 202:191–198.10.1016/j.thromres.2021.04.012 Search in Google Scholar

[10]. YU J., YUAN X., CHEN H., CHATURVEDI S., BRAUNSTEIN E.M., BRODSKY R.A. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 2020 ;136(18):2080–9.10.1182/blood.2020008248 Search in Google Scholar

[11]. NHLBI Exome Sequencing Project (ESP) Exome Variant Server [Internet]. Available from: http://evs.gs.washington.edu/EVS/ Search in Google Scholar

[12]. CAPRIOLI J., CASTELLETTI F., BUCCHIONI S., BETTINAGLIO P., BRESIN E., PIANETTI G, ET AL. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet. 2003; 12(24):3385–95.10.1093/hmg/ddg363 Search in Google Scholar

[13]. NEUMANN H.P.H., SALZMANN M., BOHNERT-IWAN B., MANNUELIAN T., SKERKA C, LENK D, et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet. 2003;40(9):676–81.10.1136/jmg.40.9.676 Search in Google Scholar

• Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren syndrome

• Acute myelogenous leukemia – current recommendations and approaches in molecular-genetic assessment

• COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant

• Peculiar encounter of sarcoidosis and solid pseudopapillary tumor of the pancreas

• Systematic Approach to Celiac Disease: A Comprehensive Review for Primary Providers

• Serum Uric Acid as a Predictor of cardio-and cerebro-vascular diseases in Maintenance Hemodialysis Patients

• Autoimmune Polyglandular Syndrome Type II presenting as Subacute Combined Degeneration of Spinal Cord: A Neuroendocrinology Crossroad

• Erratum for the paper Erfani A. Liver Fibrosis: Causes and Methods of Assessment, A Review. Rom J Intern Med. 2015;53(4):304-14.

• A Pilot Study of Changes in Urinary Podocalyxin Levels during Normal Pregnancy and Labor

• Validation of Salivary Glucose as a Screening Tool of Diabetes Mellitus

• Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations